Back to BlackRock, Inc. BlackRock, Inc.

AURAAURA
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in AURA BIOSCIENCES INC

Yes. BlackRock holds 4,707,674 shares of AURA (Aura Biosciences), worth $33.4M, as of its Q2 2026 13F filing. It increased the position by 1,121,034 shares (+31.3%) from Q1 2026. BlackRock has held AURA in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$33.4M

Current Shares

4.7M

Total Value Change

+$5.3M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.7M
+31.3%
$33.4M0.0%$7.10
37
2026-Q1
Increased
3.6M
+0.7%
$24M0.0%$6.24
29
2025-Q4
Increased
3.6M
+4.5%
$19.4M0.0%$5.49
30
2025-Q3
Increased
3.4M
+9.8%
$21M0.0%$6.17
31
2025-Q2
Decreased
3.1M
-12.4%
$19.4M0.0%$6.28
0
2025-Q1
Decreased
3.5M
-0.3%
$20.7M0.0%$6.34
0
2024-Q4
Increased
3.6M
+12.4%
$29.2M0.0%$8.22
32
2024-Q3
First report
3.2M
-
$28.2M0.0%$8.91
0

Other major holders of AURA: CITADEL ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used